Real-world Impact of Long-term Prophylaxis on the Clinical Burden of Patients with Hereditary Angioedema

Orladeyo (berotralstat) - BioCryst

Takhzyro (lanadelumab-flyo) - Takeda

Haegarda (C1 esterase inhibitor subcutaneous [human]) - CSL Behring

https://www.annallergy.org/article/S1081-1206(25)00544-7/fulltext

Cristine Radojicic; Art Zbrozek; Montserrat Vera-Llonch; Philippe Thompson-Leduc; Marjolaine Gauthier-Loiselle; Anabelle Tardif-Samson; Claire Vanden Eynde; Annie Guérin; William Lumry

Sep 16, 2025